S. Lauer

发表

Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.

M. Devidas, N. Winick, J. Pullen, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stage I and II Hodgkin's disease in the pediatric population. Long-term follow-up of patients staged predominantly clinically.

C. Schultz, J. Wilson, K. Murray, 1996, American journal of clinical oncology.

Risk-Adapted Therapy for Acute Lymphocytic Leukemia: The Pediatric Oncology Group Experience

J. Shuster, A. Carroll, J. Pullen, 1997 .

Identification of newly diagnosed children with acute lymphocytic leukemia at high risk for relapse

A. Look, J. Shuster, M. Borowitz, 1999 .

Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors.

S. Lauer, Jie Hu, M. Fritsch, 2001, Cancer research.

Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.

N. Winick, B. Camitta, D. Mahoney, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis.

E. Jaffe, F. Berthold, A. Feldman, 2005, The Lancet. Oncology.

Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.

W. London, J. Cullen, R. Giller, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Excellent outcome in patients with stage I germ cell tumors of the testes: a study of the Children's Cancer Group/Pediatric Oncology Group.

W. London, P. Colombani, J. Cullen, 2003, Journal of pediatric surgery.

Amifostine does not protect against the ototoxicity of high‐dose cisplatin combined with etoposide and bleomycin in pediatric germ‐cell tumors

W. London, A. L. Frazier, E. Perlman, 2005, Cancer.

Autoimmune lymphoproliferative syndrome: A cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children—report on diagnosis and management of five patients

Shiyong Li, C. Alvarado, K. Mann, 2004, Pediatric blood & cancer.

Failure of early intensive chemotherapy to improve prognosis in childhood acute lymphocytic leukemia.

B. Camitta, D. Pinkel, L. Kun, 1980, Medical and pediatric oncology.

Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study.

W. London, R. Giller, T. Olson, 2004, Journal of pediatric surgery.

Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T‐cell leukemia

R. G. Hoffman, R. Krance, B. Camitta, 1987, Cancer.

Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation.

R. Mulhern, R. Kline, B. Camitta, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents

M. Fritsch, E. Perlman, D. Harms, 2002, Genes, chromosomes & cancer.

Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.

J. Cullen, R. Giller, M. Krailo, 1999, American journal of obstetrics and gynecology.

Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia.

J. Shuster, M. Link, D. Haines, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Deletion mapping of 6q21-26 and frequency of 1p36 deletion in childhood endodermal sinus tumors by microsatellite analysis

M. Fritsch, E. Perlman, Jie Hu, 2001, Oncogene.

Malignant mediastinal germ cell tumors: an intergroup study.

W. London, P. Colombani, R. Giller, 2001, Journal of pediatric surgery.

Genetic analysis of childhood endodermal sinus tumors by comparative genomic hybridization.

Jie Hu, E. Perlman, R. Castleberry, 2000, Journal of pediatric hematology/oncology.

Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

A. Look, M. Borowitz, A. Carroll, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882).

C. Stolar, P. Colombani, J. Cullen, 2001, Journal of pediatric surgery.

Malignant retroperitoneal and abdominal germ cell tumors: an intergroup study.

W. London, P. Colombani, R. Giller, 2003, Journal of pediatric surgery.

Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study.

C. Stolar, J. Cullen, R. Giller, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study.

W. London, A. L. Frazier, N. Marina, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.

W. London, E. Perlman, P. Colombani, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effect of neoadjuvant chemotherapy and surgery in children with malignant germ cell tumors of the genital region: a pediatric intergroup trial.

W. London, P. Colombani, J. Cullen, 2003, Journal of pediatric surgery.

Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .

B. Pollock, A. Ritchey, G. Buchanan, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study.

S. Smith, N. Winick, M. Wharam, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant alpha‐2B interferon treatment for childhood t‐lymphoblastic disease in relapse. A pediatric oncology group phase II study

B. Pollock, G. Buchanan, S. Lauer, 1994, Cancer.

Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study.

J. Shuster, C. Civin, B. Camitta, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive Alternating Drug Pairs After Remission Induction for Treatment of Infants With Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Pilot Study

J. Shuster, A. Carroll, J. Pullen, 1998, Journal of pediatric hematology/oncology.

Accumulation of High Levels of Methotrexate Polyglutamates in Lymphoblasts From Children With Hyperdiploid ( > 50 chromosomes ) B-Lineage Acute Lymphoblastic Leukemia : A Pediatric Oncology Group Study

J. Shuster, A. Carroll, B. Camitta, 2003 .

Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study.

J. Shuster, B. Camitta, D. Mahoney, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial.

N. Winick, B. Camitta, R. Nitschke, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B—lineage acute lymphoblastic leukemia. A pediatric oncology group pilot study

J. Shuster, B. Camitta, B. Leventhal, 1995, Cancer.

Intensive alternating drug pairs for treatment of high‐risk childhood acute lymphoblastic leukemia. A pediatric oncology group pilot study

J. Shuster, C. Civin, J. Pullen, 1993, Cancer.

Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.

J. Shuster, D. Johnston, M. Devidas, 2007, Cancer genetics and cytogenetics.

Plasma Methotrexate, Red Blood Cell Methotrexate, and Red Blood Cell Folate Values and Outcome in Children With Precursor B-acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Xiaomin Lu, J. Shuster, M. Devidas, 2012, Journal of pediatric hematology/oncology.

Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

J. Shuster, M. DeBaun, B. Pollock, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

A. Look, B. Camitta, L. Cooley, 2005, Leukemia.

Effectiveness of a six‐drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children

B. Camitta, L. Kun, J. Casper, 1985, Cancer.

Childhood primary cutaneous non‐T/non‐B lymphoma followed by acute T‐cell leukemia

B. Camitta, S. Lauer, T. T. Tang, 1986, Cancer.

Terminal transferase surveillance of remission bone marrows in childhood acute lymphoblastic leukemia: improved sensitivity with countercurrent centrifugal elutriation.

B. Camitta, S. Lyman, J. Casper, 1985, Journal of clinical & laboratory immunology.

Racial D ifferences i n t he S urvival o f C hildhood B - Precursor A cute L ymphoblastic L eukemia: A P ediatric Oncology G roup S tudy

J. Shuster, M. DeBaun, B. Pollock, 2000 .

High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis.

J. Shuster, M. Link, D. Haines, 1996, Blood.

Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study.

B. Camitta, B. Leventhal, D. Strother, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study.

M. Cleary, S. Hunger, A. Carroll, 1998, Blood.

Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis.

Ronald T. Brown, G. Walco, S. Lauer, 1998, Journal of pediatric psychology.

Identification of leukemic cells in the cerebrospinal fluid from children with acute lymphoblastic leukemia: advances and dilemmas.

B. Camitta, S. Lauer, P. Kirchner, 1989, The American journal of pediatric hematology/oncology.

Evaluation of cerebrospinal fluid mononuclear cells obtained from children with acute lymphocytic leukemia: advantages of combining cytomorphology and terminal deoxynucleotidyl transferase.

B. Camitta, J. Casper, S. Lauer, 1983, American journal of clinical pathology.

Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

A. Look, J. Shuster, Y. Ravindranath, 1998, Leukemia & lymphoma.

Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine.

B. Camitta, B. Kamen, J. Holcenberg, 1986, Cancer treatment reports.

Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study.

A. Look, M. Borowitz, A. Carroll, 1997, Blood.